Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185